National Kidney Disease Education Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Am J Kidney Dis. 2018 Mar;71(3):407-411. doi: 10.1053/j.ajkd.2017.09.017. Epub 2017 Dec 6.
Despite extensive clinical guidelines, innovative efforts to improve care, and well-funded efforts to raise awareness, limited progress has been made in reducing the burden of kidney disease in the United States, and the prevalence continues to increase worldwide. The Indian Health Service and the Centers for Disease Control and Prevention recently reported a 54% decrease in the incidence of kidney failure among American Indian and Alaska Native people with diabetes. This decrease in end-stage renal disease incidence was associated with a population health approach to diabetes care based in the community and the primary clinical setting. The effort focused on integrating better care for kidney disease within the context of routine diabetes care. Although the American Indian population and the Indian Health Service may be unfamiliar to many clinicians and health system administrators, the demonstration that simple evidence-based interventions implemented in a comprehensive and consistent way can reduce the burden of end-stage renal disease suggests that population-based approaches to chronic disease offer significant potential benefits. Large pragmatic trials may offer the best way to rigorously test this hypothesis.
尽管有广泛的临床指南、创新的努力来改善医疗服务,以及资金充足的提高认识的努力,但在美国,减轻肾脏疾病负担的进展有限,全球的患病率仍在继续上升。美国印第安人事务局和疾病控制与预防中心最近报告称,糖尿病患者的美国印第安人和阿拉斯加原住民的肾衰竭发病率下降了 54%。这种终末期肾病发病率的下降与一种基于社区和初级临床环境的糖尿病护理人群健康方法有关。这项工作的重点是在常规糖尿病护理的背景下更好地整合肾脏疾病的护理。尽管许多临床医生和卫生系统管理人员可能不熟悉美国印第安人口和美国印第安人事务局,但这一证明表明,在全面和一致的基础上实施简单的基于证据的干预措施可以减轻终末期肾病的负担,这表明基于人群的慢性病管理方法具有很大的潜在益处。大型实用临床试验可能是严格检验这一假设的最佳方法。